DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Bupivacaine hydrochloride; epinephrine bitartrateis the generic ingredient in four branded drugs marketed by Hospira, Septodont, and Fresenius Kabi Usa, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.
There are twelve drug master file entries for bupivacaine hydrochloride; epinephrine bitartrate. Eight suppliers are listed for this compound.
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Identify potential brand extensions & 505(b)(2) entrants
|Sunnybrook Health Sciences Centre||N/A|
|Cosmozone Dental Clinic||N/A|
Pharmacology for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
|Drug Class||Amide Local Anesthetic |
|Mechanism of Action||Adrenergic alpha-Agonists |
|Physiological Effect||Local Anesthesia |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.